Corinne Le Goff | President, Chief Executive Officer |
Jeffrey Church | Chief Financial Officer |
Khursheed Anwer | Chief Science Officer |
Kim Golodetz | Investor Relations |
Emily Bodnar | HC Wainwright |
David Bautz | Zacks |
Kemp Dolliver | Brooklyn Capital Markets |
James Molloy | Alliance Global Partners |
Good morning. My name is Alan, and I will be your operator today. At this time I would like to welcome you to Imunon's Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
I would like now to turn the call over to Kim Golodetz.